MAEA overexpression in primary mouse liver cells attenuates hepatic gluconeogenesis and reduces the risk of insulin resistance, which may improve type 2 diabetes mellitus [101,102]. The gene discussed is MAEA; the disease is type 2 diabetes mellitus.